EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Clinical Prognostic Impact of the Serum C-reactive Protein-to-albumin Ratio (CAR) in Chronic Heart Failure Patients: A Retrospective Study

Chenggong Xu, Ningli Zhang, Wei Rong, Ling Dong, Wenyi Gu, Jie Zou, Na Zhu, Tao Shi, Hao Li, Lixing Chen iD

Reviews in Cardiovascular Medicine · 25.12.2024 · 25 (12)

DOI: 10.31083/j.rcm2512461 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Reviews in Cardiovascular Medicine, online erschienen am 25.12.2024. Verfasst von Chenggong Xu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, The First Affiliated Hospital of Kunming Medical University, 650032 Kunming, Yunnan, China. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Yunnan Provincial Health Commission Clinical Medical Center, Applied Basic Research Program of the Science and Technology Hall of Yunnan Province and Kunming Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The serum C-reactive protein-to-albumin ratio (CAR) has been identified as an adverse prognostic indicator in a variety of diseases. Nevertheless, there have been not been any studies reporting a relationship between CAR and the prognosis of chronic heart failure (CHF). This study was designed to evaluate the association between CAR and all-cause mortality in CHF patients with different ejection fractions.

Methods

A total of 1221 heart failure (HF) patients were enrolled at the First Affiliated Hospital of Kunming Medical University due to acute exacerbation of chronic HF from January 2017 to October 2021. The main outcome was all-cause mortality. After collecting baseline characteristics and laboratory results from all patients, we classified all participants into four groups based on CAR quartile (G1–G4). Kaplan-Meier survival curves and multivariate Cox proportional hazard models were employed to investigate the association between CAR and all-cause mortality in the patients. Furthermore, receiver operating characteristic (ROC) curves were constructed for CARs, and the area under the curve (AUC) was calculated.

Results

After excluding ineligible patients, we ultimately included 1196 patients with CHF. The mean age was 66.38 ± 12.521 years, and 62% were male. According to the Kaplan‒Meier analysis, with different ejection fractions, the risk of all-cause mortality was always highest for G4 (CAR >63.27) and lowest for G1 (CAR ≤7.67). Cox multivariate regression analyses indicated that the CAR was an independent predictor of all-cause mortality in all HF patients and in patients with different HF subtypes. According to the ROC curves, the AUC for the CAR was 0.732 (p < 0.001), with a sensitivity of 66.2% and the specificity of 72.7%. CAR had a greater predictive value for all-cause mortality than did C-reactive protein (CRP).

Conclusions

An elevated serum CAR was independently associated with an increased risk of all-cause death, regardless of heart failure subtype.

Schlagwörter

Stichwörter der Autor:innen

C-reactive proteinC-reactive protein-to-albumin ratioheart failure with different ejection fractionsmortalityprognosis

Autor:innen und Institutionen

  • Department of Cardiology, The First Affiliated Hospital of Kunming Medical University, 650032 Kunming, Yunnan, China.
  • Department of Anesthesiology, The Second Affiliated Hospital of Kunming Medical University, 650101 Kunming, Yunnan, China.
  • Department of Neurology, The Second Affiliated Hospital of Kunming Medical University, 650101 Kunming, Yunnan, China.

ORCID-Profile: Lixing Chen

Förderung

  • Yunnan Provincial Health Commission Clinical Medical Center
  • Applied Basic Research Program of the Science and Technology Hall of Yunnan Province and Kunming Medical University

Zitieren

APA

Xu, C., Zhang, N., Rong, W., Dong, L., Gu, W., Zou, J., Zhu, N., Shi, T., Li, H., & Chen, L. (2024). Clinical Prognostic Impact of the Serum C-reactive Protein-to-albumin Ratio (CAR) in Chronic Heart Failure Patients: A Retrospective Study. Reviews in Cardiovascular Medicine, 25(12). https://doi.org/10.31083/j.rcm2512461

Vancouver

Xu C, Zhang N, Rong W, Dong L, Gu W, Zou J, et al. Clinical Prognostic Impact of the Serum C-reactive Protein-to-albumin Ratio (CAR) in Chronic Heart Failure Patients: A Retrospective Study. Reviews in Cardiovascular Medicine. 2024;25(12). doi:10.31083/j.rcm2512461

BibTeX
@article{Xu2024,
  author = {Xu, Chenggong and Zhang, Ningli and Rong, Wei and Dong, Ling and Gu, Wenyi and Zou, Jie and Zhu, Na and Shi, Tao and Li, Hao and Chen, Lixing},
  title = {Clinical Prognostic Impact of the Serum C-reactive Protein-to-albumin Ratio (CAR) in Chronic Heart Failure Patients: A Retrospective Study},
  journal = {Reviews in Cardiovascular Medicine},
  year = {2024},
  volume = {25},
  number = {12},
  doi = {10.31083/j.rcm2512461}
}
Kostenlos starten →